Immunotherapy in Hepatocellular Carcinoma

Immunotherapy in Hepatocellular Carcinoma

Based on this evidence, a deep understanding of the immunological status and biological targets modulating immunological microenvironments should be quite informative for the development of future immunotherapy in HCC. From this point of view, this Special Issue will highlight the current state of t...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Medicine and Nursing
Oncology
a disintegrin and metalloprotease 9
alpha fetoprotein response
anti-VEGF inhibitor
biomarkers
cancer immunotherapy
CD14+ cells
check-point inhibitors
combination immunotherapy
combination therapies
combination therapy
copy number variations
CTLA-4
effectiveness
genetic alteration
HCC
hepatocellular carcinoma
hepatocellular carcinoma (HCC)
immune checkpoint blockade
immune checkpoint inhibition
immune checkpoint inhibitor
immune phenotype
immune-related adverse events (irAEs)
immunotherapy
liver cancer
liver disease
microRNAs
molecular classification
molecular-targeted agent
mutations
natural killer
nivolumab
oncogenic signal
outcome
PD-1
PD-1 antibody
PD-L1
PD-L1 antibody
predictive factors
predictive markers
programmed death 1 ligands
safety
stem cell marker
TACE
TCGA
therapy resistance
tissue-resident memory CD8 T cells
translational approaches
tyrosine kinase inhibitor
unresectable hepatocellular carcinoma
β-catenin
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Internet

Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Similar Items